Hurdle

Hurdle is a diagnostics-as-a-service platform with a mission to democratize access to biology for companies and consumers. Founded in 2017 and headquartered in the United Kingdom, the company's platform integrates seamlessly with any business system, offering modular and end-to-end capabilities to make biology data accessible and actionable. The platform is designed to break down traditional barriers and act as a catalyst for change by leveraging the power of biology to drive informed decision-making.

With a focus on Health Care, Health and Wellness, and Clean Energy industries, Hurdle aims to propel businesses and the world into a brighter future. The company secured a Convertible Note investment on 13 September 2023 from SOSV, signaling confidence in its vision and potential. As a brand under Chronomics Ltd. Inc., Hurdle is committed to unlocking biology's untapped potential and empowering organizations with deep insights to thrive.

For more information, visit hurdle.bio.